Bone Biologics Corp (BBLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 690 | -44,994 | 230 | 232 | 181 |
| Operating Income | -690 | 44,994 | -230 | -232 | -181 |
| Interest Expense | 0 | 14 | 280 | 260 | 251 |
| Other Income | 0 | -45,158 | 0 | 0 | 0 |
| Pre-tax Income | -690 | -178 | -509 | -492 | -432 |
| Net Income Continuous | -690 | -178 | -509 | -492 | -432 |
| Net Income | $-690 | $-178 | $-509 | $-492 | $-432 |
| EPS Basic Total Ops | -100.88 | 201.76 | -245.00 | -245.00 | -216.17 |
| EPS Basic Continuous Ops | -96.00 | 198.33 | -252.14 | -243.52 | -213.72 |
| EPS Diluted Total Ops | -100.88 | 201.76 | -245.00 | -245.00 | -216.17 |
| EPS Diluted Continuous Ops | -96.00 | 198.33 | -252.14 | -243.52 | -213.72 |
| EBITDA(a) | $-690 | $44,994 | $-230 | $-232 | $-181 |